New drug combo shows promise for advanced liver cancer
Disease control
Ongoing
This study tests a combination of two drugs, pembrolizumab and bavituximab, in people with advanced liver cancer that cannot be treated with surgery or local therapies. About 35 participants will receive the treatment to see how many respond and how safe it is. The goal is to fin…
Phase: PHASE2 • Sponsor: David Hsieh • Aim: Disease control
Last updated May 04, 2026 16:21 UTC